+499.5%
MRNA vs BROS
-35.3%
+534.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BROS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.7% | -3.0% | -2.6% |
| 7D | +5.5% | -6.7% | +12.2% | +8.4% |
| 30D | +158.7% | -29.1% | +187.8% | +181.3% |
| 3M | +182.1% | -16.7% | +198.8% | +199.2% |
| 6M | +151.8% | -11.6% | +163.4% | +163.2% |
| YTD | +393.6% | -23.9% | +417.5% | +426.4% |
| 1Y | +499.5% | -34.8% | +534.3% | +487.9% |
| All | +499.5% | -35.3% | +534.8% | +487.9% |
Cumulative growth
Daily Returns
Daily percentage return beside BROS.
Daily Out/Under-Performance
Portfolio return minus BROS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BROS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BROS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling